Correlation Between SAB Biotherapeutics and Bruker
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Bruker at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Bruker into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Bruker, you can compare the effects of market volatilities on SAB Biotherapeutics and Bruker and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Bruker. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Bruker.
Diversification Opportunities for SAB Biotherapeutics and Bruker
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between SAB and Bruker is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Bruker in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bruker and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Bruker. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bruker has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Bruker go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Bruker
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 61.15 times more return on investment than Bruker. However, SAB Biotherapeutics is 61.15 times more volatile than Bruker. It trades about 0.16 of its potential returns per unit of risk. Bruker is currently generating about -0.02 per unit of risk. If you would invest 2.15 in SAB Biotherapeutics on September 25, 2024 and sell it today you would earn a total of 5.56 from holding SAB Biotherapeutics or generate 258.6% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 74.6% |
Values | Daily Returns |
SAB Biotherapeutics vs. Bruker
Performance |
Timeline |
SAB Biotherapeutics |
Bruker |
SAB Biotherapeutics and Bruker Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SAB Biotherapeutics and Bruker
The main advantage of trading using opposite SAB Biotherapeutics and Bruker positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Bruker can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will offset losses from the drop in Bruker's long position.SAB Biotherapeutics vs. Fate Therapeutics | SAB Biotherapeutics vs. Caribou Biosciences | SAB Biotherapeutics vs. Karyopharm Therapeutics | SAB Biotherapeutics vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |